Masimo Faces Sanctions Bid Over Discovery In FCA Fight

Law360, New York (September 18, 2013, 3:21 PM EDT) -- Patient-monitoring tech firm Masimo Corp. withheld evidence in a False Claims Act case over Medicare reimbursements for allegedly defective medical devices, relators in the case told a California federal judge in a motion for sanctions on Tuesday.

The relators, former Masimo sales representatives selling the noninvasive hemoglobin devices called Radical-7, Pronto and Pronto-7, say that Masimo, which is accused of fraudulently causing an array of government programs to pay reimbursements for defective hemoglobin measurement devices, did not cooperate with discovery requests about details of its sales....
To view the full article, register now.